These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9502775)

  • 21. GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor.
    Yang H; Egan JM; Wang Y; Moyes CD; Roth J; Montrose MH; Montrose-Rafizadeh C
    Am J Physiol; 1998 Sep; 275(3):C675-83. PubMed ID: 9730951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracerebroventricular injection of glucagon-like peptide-1 decreases monoamine concentrations in the hypothalamus of chicks.
    Tachibana T; Tanaka S; Furuse M; Hasegawa S; Kato H; Sugahara K
    Br Poult Sci; 2002 Mar; 43(1):122-6. PubMed ID: 12003328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence.
    Serre V; Dolci W; Schaerer E; Scrocchi L; Drucker D; Efrat S; Thorens B
    Endocrinology; 1998 Nov; 139(11):4448-54. PubMed ID: 9794451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells.
    Zhou J; Wang X; Pineyro MA; Egan JM
    Diabetes; 1999 Dec; 48(12):2358-66. PubMed ID: 10580424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
    Widmann C; Dolci W; Thorens B
    Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2.
    Schepp W; Schmidtler J; Riedel T; Dehne K; Schusdziarra V; Holst JJ; Eng J; Raufman JP; Classen M
    Eur J Pharmacol; 1994 Oct; 269(2):183-91. PubMed ID: 7851494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro.
    Dalvi PS; Nazarians-Armavil A; Purser MJ; Belsham DD
    Endocrinology; 2012 May; 153(5):2208-22. PubMed ID: 22334721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The central corticotropin-releasing factor and glucagon-like peptide-1 in food intake of the neonatal chick.
    Furuse M; Matsumoto M; Saito N; Sugahara K; Hasegawa S
    Eur J Pharmacol; 1997 Nov; 339(2-3):211-4. PubMed ID: 9473137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.
    During MJ; Cao L; Zuzga DS; Francis JS; Fitzsimons HL; Jiao X; Bland RJ; Klugmann M; Banks WA; Drucker DJ; Haile CN
    Nat Med; 2003 Sep; 9(9):1173-9. PubMed ID: 12925848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
    Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
    Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of functional opioid delta receptors in a luteinizing hormone-releasing hormone-producing neuronal cell line.
    Maggi R; Pimpinelli F; Martini L; Piva F
    Endocrinology; 1995 Jan; 136(1):289-95. PubMed ID: 7828543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
    Perry T; Lahiri DK; Sambamurti K; Chen D; Mattson MP; Egan JM; Greig NH
    J Neurosci Res; 2003 Jun; 72(5):603-12. PubMed ID: 12749025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release.
    Dillon JS; Lu M; Bowen S; Homan LL
    Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):182-9. PubMed ID: 15789279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats.
    Gülpinar MA; Bozkurt A; Coşkun T; Ulusoy NB; Yegen BC
    Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G924-9. PubMed ID: 10859222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of 125I-[Y39]exendin-4 to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig.
    Singh G; Eng J; Raufman JP
    Regul Pept; 1994 Aug; 53(1):47-59. PubMed ID: 7800858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats.
    Schick RR; Zimmermann JP; vorm Walde T; Schusdziarra V
    Am J Physiol Regul Integr Comp Physiol; 2003 Jun; 284(6):R1427-35. PubMed ID: 12776726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of specific binding sites for glucagon-like peptide-1 on the posterior lobe of the rat pituitary.
    Göke R; Larsen PJ; Mikkelsen JD; Sheikh SP
    Neuroendocrinology; 1995 Aug; 62(2):130-4. PubMed ID: 8584112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent.
    Doyle ME; Greig NH; Holloway HW; Betkey JA; Bernier M; Egan JM
    Endocrinology; 2001 Oct; 142(10):4462-8. PubMed ID: 11564711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.
    Sancho V; Trigo MV; González N; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
    J Mol Endocrinol; 2005 Aug; 35(1):27-38. PubMed ID: 16087719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3',5'-monophosphate, and glucocorticoids.
    Abrahamsen N; Nishimura E
    Endocrinology; 1995 Apr; 136(4):1572-8. PubMed ID: 7534705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.